Morning Market Losers
April 27, 2015 at 09:53 AM EDT
Celladon Corp (NASDAQ: CLDN) shares dipped 78.95 percent to $2.88 on the failed CUPID2 trial of MYDICAR in advanced heart ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.